Top 15 Life Science Startup Investors in Ireland (October 2026)

Portfolio highlights

• Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
• Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
• Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.

Portfolio highlights

• Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
• Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
• Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.

Portfolio highlights

• NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
• Offr — Offr is the new way to buy and sell property, quickly and transparently.
• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• SolveAI —
• Smarterer — Individuals and Fortune 500 companies use Smarterer to help close the gap between the skills they have and the skills they need. Their dynamic assessment engine leverages the freshest crowdsourced tests around, to rapidly pinpoint skill level with a credible score. In November 2014, Pluralsight, the global leader in online learning for serioussoftware developers, IT specialists and creative technologists, acquired Smarterer. As the world's largest curated e-learning library for professionals, the company offers instant access to more than 3,500 courses authored by top experts. Smarterer will continue to power crowdsourced assessments for freelancer marketplaces, e-learning providers and enterprise companies anywhere people need to prove their skills to connect with professional opportunities. The Smarterer community has answered over 56 million during 1.7 million test sessions, across hundreds of tests.
• EveryONE Medicines — EveryONE Medicines develops nucleic acid therapeutics for pathogenic genetic mutation of patients.

Portfolio highlights

• equal1 — Equal1 Quantum System-on-a-Chip (QSoC) integrates all essential quantum computer elements onto a single chip, powering our scalable, datacenter-ready quantum servers.
• Manna Air Delivery — Drone delivery made simple
• CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.

Portfolio highlights

• Proba — Unlock the value of your climate actions with Proba. Transform your efforts into tradable carbon certificates, connect with partners, and create new revenue streams for your business. Schedule a call now.
• Produzindo Certo — Produzindo Certo focuses on providing solutions in the farming industry. The company offers a digital platform that automates agricultural processes, aiming to enhance efficiency and sustainability. It engages in projects that promote responsible farming practices, including carbon management and sustainable soybean production. The companycollaborates with ranchers and other stakeholders to implement pilot projects that transform social and environmental practices in agriculture.
• Ascribe Bioscience — Ascribe develops natural crop protection products that help farmers reduce disease and increase yield without harming the environment or human health.

Portfolio highlights

• Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
• Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
• Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.

Portfolio highlights

• Synchron — The endovascular brain computer interface.
• Ramona — At Ramona, we’re creating a high-throughput microscopy toolset to unlock a new perspective on cellular-level research. With a wider field of view and the capacity to capture data synchronously, we see more — and we see it in motion. By providing a new point of view, our technology enables researchers to make more informed decisions, faster.
• Moonwalk Biosciences — By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.

Portfolio highlights

• Zartis — Zartis is a global technology consulting partner specialising in AI transformation and advanced engineering. We help organisations integrate AI across their teams, systems, and products - turning ambition into practical, production-ready capability.
• IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
• Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.

Portfolio highlights

• ice — Ice.com is one of the leading e-commerce website that sells diamonds, engagement rings, watches, earrings and all other types of jewelry. It raised $47 million from Polaris Venture Partners and Ignition Partners. The online retailer opened its doors in 1999 and has grown to annual sales of $83.4 million.
• RetireOne — The outsourced insurance desk of choice for RIAs features low-cost, zero commission annuities for fee-only fiduciaries that are simple + transparent.
• Cushcraft Corp. — Cushcraft Corp. designs, develops, manufactures, and distributes antennas and other passive radio frequency (RF) products for broadband wireless, communications, and data connectivity solutions.

Portfolio highlights

• RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
• MedinCell — Join Medincell on a journey to transform global health with innovative therapies.
• Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.

Portfolio highlights

• Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
• GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
• Comera Life Sciences — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.

Portfolio highlights

• TECLens — TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore.
• Triastek — Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
• Tempo Therapeutics — Tempo Therapeutics is a biotechnology and tissue engineering company based out of San Diego, CA specializing in speeding up patient recovery.